Gout

A healthy plant-based diet can help mitigate gout risk, especially for women, according to the results of research published in JAMA Network Open.

Among patients with gout, those with cardiovascular monosodium urate deposits, confirmed via dual energy CT, demonstrate a higher risk for major adverse cardiac events, according to data published in Rheumatology.

Approximately 26% of patients with gout are commonly prescribed colchicine prophylaxis despite already using medications with potential interactions, according to data published in Rheumatology.

DESTIN, Fla. — Patients with gout should be continually reminded that urate-lowering therapy may go on for the rest of their life, according to a speaker at the Congress of Clinical Rheumatology East annual meeting.

The month of May serves as Arthritis Awareness Month, drawing attention to this all-too common, yet misunderstood, condition.

Approximately 23% of patients with chronic kidney disease meet the criteria for gout, of whom 13% have uncontrolled gout and 36% have no formal gout diagnosis, according to data published in Gout, Urate, and Crystal Deposition Disease.

The use of thermal imaging and the ALT-70 prediction model were helpful in differentiating cellulitis from pseudocellulitis, reducing misdiagnosis, according to a study.

Patients with higher baseline serum urate levels demonstrate increased recurrent gout hospitalization rates and subsequent risk for flare over 10 years of follow-up, according to data published in JAMA.

Excess risk for cardiovascular disease in patients with gout — including heart failure and arrhythmias — is highest among women and those aged younger than 45 years, according to data published in The Lancet Rheumatology.

The risk for gout flare when initiating urate lowering therapy varies based on the drug and dosing strategy used, according to a systematic review and network meta-analysis published in Arthritis Care & Research.